Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Avatarhashon Jan 28, 2019 2:01pm
110 Views
Post# 29289474

RE:Aphria GMP / EU-GMP Certification - Reference

RE:Aphria GMP / EU-GMP Certification - ReferenceSo why do we need EU-GMP certification in that case?
ProfMoische wrote:
Here are the references for anyone interested in learning more about the GMP cert. I am posting this for reference. Bold is mine for emphasis:

MRA and collaboration on GMP compliance
The EU and Canada signed a MRA on GMP. This allows EU authorities and their Canadian counterparts to:
 
1. rely on each other's GMP inspections;
2. waive batch testing of products on entry into their territories;
3. share information on inspections and quality defects.
4. For more information on MRAs and the scope of the EU-Canada MRA, see Mutual recognition agreements.
 
EMA also participates in initiatives with partner authorities, including Health Canada, on GMP inspections which aim to better distribute inspections capacity, allowing more sites to be monitored and reducing unnecessary duplication. For more information, see International collaboration on GMP inspections.
 
Mutual recognition agreements (MRAs) on good manufacturing practice (GMP) allow EU authorities to rely on GMP inspections performed by other regulators, the waiving of re-testing of products imported into the EU, and information sharing on inspections and quality defects of products. The EU has MRAs in place with Australia, Canada, Japan, New Zealand, Switzerland and US, and a similar agreement with Israel (ACAA: agreement on conformity assessment and acceptance of industrial products).
 
In addition to the above, the European Commission together with EMA cooperates with many other regulatory authorities from non-EU countries. Regulatory dialogue with Chinese Taipei takes the form of video conference meetings held every six months and chaired by DG TRADE, in addition to the mid-term review meeting. Regular meetings also take place with the Republic of Korea (in the context of the Free Trade Agreement). In addition, DG TRADE has also engaged in FTA negotiations with Australia, Chile, Indonesia, Japan, Mexico, New Zealand, Philippines, and recently concluded negotiations with Vietnam. Pharmaceuticals are part of the FTAs.
 
References: 
 
https://ec.europa.eu/health/human-use/good_manufacturing_distribution_practices_en
 
https://www.ema.europa.eu/documents/other/questions-answers-impact-mutual-recognition-agreement-between-european-union-united-states-1_en.pdf
 
https://www.ema.europa.eu/en/news/five-additional-countries-benefit-eu-us-mutual-recognition-agreement-inspections
 
https://www.ema.europa.eu/en/human-regulatory/research-development/compliance/good-manufacturing-practice/mutual-recognition-agreements-mra
 
https://www.pharmacompass.com/radio-compass-blog/fda-and-eu-differ-on-cgmp-standards-at-the-same-facilities-how-will-they-mutually-recognize-inspections


Bullboard Posts